Newcourt Acquisition Corp is a blank check company incorporated on February 25, 2021 as a Cayman Islands company for the purpose of effecting a merger, capital exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Report as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to the initial public offering and searching for a potential target for the initial business combination.
Company profile
Ticker
PBM
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
PBM stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
5 Feb 24
8-K
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
31 Jan 24
25-NSE
Exchange delisting
26 Jan 24
8-K
Entry into a Material Definitive Agreement
24 Jan 24
425
Business combination disclosure
23 Jan 24
8-K
Newcourt Acquisition Corp Announces Continuation
23 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
22 Jan 24
8-K
Other Events
22 Jan 24
425
Business combination disclosure
22 Jan 24
Latest ownership filings
SC 13G/A
GLAZER CAPITAL, LLC
14 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13D/A
Newcourt SPAC Sponsor LLC
16 Jan 24
4
Marc Gregory Balkin
16 Jan 24
4
Change in insider ownership
17 Jul 23
3
de Vyver Jurgen Johannes van
22 Jun 23
3/A
Initial statement of insider ownership (amended)
8 Mar 23
4
Change in insider ownership
8 Mar 23
3
Initial statement of insider ownership
23 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
15 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 88.17 k | 88.17 k | 88.17 k | 88.17 k | 88.17 k | |
Cash burn (monthly) | (no burn) | 10.56 k | 185.68 k | 195.96 k | 45.85 k | |
Cash used (since last report) | n/a | 75.59 k | 1.33 mm | 1.40 mm | 328.09 k | |
Cash remaining | n/a | 12.59 k | -1.24 mm | -1.31 mm | -239.91 k | |
Runway (months of cash) | n/a | 1.2 | -6.7 | -6.7 | -5.2 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 47 |
Opened positions | 4 |
Closed positions | 5 |
Increased positions | 3 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 12.94 bn |
Total shares | 18.82 mm |
Total puts | 0.00 |
Total calls | 108.00 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Newcourt SPAC Sponsor | 7.46 mm | $76.64 mm |
Integrated Core Strategies | 1.66 mm | $0.00 |
EHP Funds | 1.23 mm | $29.34 mm |
Polar Asset Management Partners | 933.00 k | $2.27 bn |
Periscope Capital | 817.73 k | $856.54 mm |
Shaolin Capital Management | 686.34 k | $1.39 mm |
MMCAP International Inc. SPC | 600.00 k | $16.32 mm |
LMR Partners | 600.00 k | $4.51 bn |
Cantor Fitzgerald, L. P. | 562.00 k | $1.88 bn |
Calamos Advisors | 500.00 k | $13.80 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 24 | Marc Gregory Balkin | Class A Ordinary Shares, par value $0.0001 | Other | Acquire J | Yes | No | 0 | 7,455,000 | 0.00 | 7,455,000 |
10 Jan 24 | Marc Gregory Balkin | Private Warrants Ordinary Shares | Other | Acquire J | Yes | No | 11.5 | 460,000 | 5.29 mm | 460,000 |
11 Jul 23 | Polar Asset Management Partners | Class A ordinary shares, par value $0.0001 per share, includ | Other | Dispose J | Yes | No | 11.07 | 130,000 | 1.44 mm | 200,000 |
6 Mar 23 | Goldman Sachs | Common Stock | Sell | Dispose S | Yes | No | 10.58 | 3,749 | 39.66 k | 0 |
6 Mar 23 | Goldman Sachs | Equity Swap Common stock | Buy | Acquire P | Yes | No | 0 | 3,749 | 0.00 | 0 |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
1 May 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
1 May 24
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
17 Apr 24
Psyence Biomed Announces Phase IIb Clinical Trial Listing On The Australian New Zealand Clinical Trials Registry
17 Apr 24
12 Health Care Stocks Moving In Friday's After-Market Session
22 Mar 24
Press releases
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
26 Mar 24
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
18 Mar 24
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
15 Mar 24
Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?
7 Feb 24